Fig. 2From: Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&Ta Boxplot of PDav per bone lesion of TSV and TSVweighted compared to MC. b Bland-Altman plotBack to article page